The Commerce Department will lead 20 U.S. companies in efforts to expand their businesses into the Japan and South Korea healthcare and energy sectors as part of the agency’s business development mission.
Commerce Secretary Penny Pritzker said Thursday the program will kick off this month with the goal to help U.S. businesses further their exports to both countries.
“One of our key functions at the Department of Commerce is to connect U.S. businesses with new opportunities to sell their goods and services in markets with significant potential,†said Pritzker.
“Throughout this trade mission, our American business leaders will help deepen and strengthen our commercial ties in the Asia-Pacific region, while also finding new markets for their goods and services,” she added.
The companies are:
- Abbott
- AmerisourceBergen
- Beautiful Earth Group
- C3 Energy
- Cargill
- Cytori Therapeutics
- Dow Chemical
- Eli Lilly and Co.
- HPI
- Humacyte
- Intuitive Surgical
- Marmon Engineered Wire and Cable
- Medidata Solutions
- Merck & Co.
- Oregon LNG
- Principle Power Inc.
- Quality Electrodynamics
- Spacelabs Healthcare
- Varian Medical Systems
- Zilkha Biomass Fuels
The government and private sector in Japan have invested $153 billion in the medical and health markets while South Korea’s drugs and medical device market size amounts to approximately $21 billion combined, Commerce says.
